The case of a man diagnosed with hemophilia A after a minor injury caused eye bleeding highlights this symptom as a rare first disease sign.

Beqvez, a discontinued gene therapy for hemophilia B, reduces joint bleeding in patients, new data from Phase 3 clinical ...

Columnist Allyx Formalejo says that she and her husband, Jared, are managing hemophilia in a less impulsive and more ...

Columnist G Shellye Horowitz applied the advocacy she learned on her hemophilia journey to get a new rare diagnosis. She ...

Today, we're seeing more women with hemophilia diagnosed earlier, but there's still work to do, says columnist.

Driving through the orchard, watching the leaves shimmer and fall, I came to understand something that brought me peace. Much of my life as a mother, advocate, and chaplain has been shaped by routines ...

Every woman with a bleeding disorder knows about doubt, writes columnist. But it's important to keep speaking out.

Asking for help has always been difficult for columnist G Shellye Horowitz, but empathy for her daughter finally allowed her ...

Data from a primate study suggested MGX-001 has potential as a hemophilia A treatment, moving the drug closer to clinical trials.

Hemophilia is a blood disorder that is characterized by a shortage of specific clotting factors that help to form blood clots and stop bleeding. Historically, the primary treatment for hemophilia is ...

Novo Nordisk has submitted an application to the U.S. Food and Drug Administration seeking approval to market Mim8 (denecimig), an injection therapy for preventing bleeds in people with hemophilia A ...

Centessa Pharmaceuticals is discontinuing the clinical development of SerpinPC, its experimental under-the-skin therapy for people with hemophilia A and hemophilia B with or without inhibitors. The ...